Numerous studies have suggested that memories ''destabilize" and require de novo protein synthesis in order to reconsolidate following retrieval, but very little is known about how this destabilization process is regulated. Recently, ubiquitin-proteasome mediated protein degradation has been identified as a critical regulator of memory trace destabilization following retrieval, though the specific mechanisms controlling retrieval-induced changes in ubiquitin-proteasome activity remain equivocal. Here, we found that proteasome activity is increased in the amygdala in a CaMKII-dependent manner following the retrieval of a contextual fear memory. We show that in vitro inhibition of CaMKII reversed retrievalinduced increases in proteasome activity. Additionally, in vivo pharmacological blockade of CaMKII abolished increases in proteolytic activity and activity related regulatory phosphorylation in the amygdala following retrieval, suggesting that CaMKII was ''upstream" of protein degradation during the memory reconsolidation process. Consistent with this, while inhibiting CaMKII in the amygdala did not impair memory following retrieval, it completely attenuated the memory impairments that resulted from post-retrieval protein synthesis blockade. Collectively, these results suggest that CaMKII controls the initiation of the memory reconsolidation process through regulation of the proteasome.
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Introduction
The formation of long-term fear memories requires de novo gene transcription and protein translation in neurons during memory consolidation (Johansen, Cain, Ostroff, & LeDoux, 2011; McGaugh, 2000) . While once thought to be permanent, it is now widely supported that upon retrieval once consolidated memories ''destabilize" and require new protein synthesis in order to ''restabilize", a process referred to as memory reconsolidation (Alberini & Ledoux, 2013; Nader, Schafe, & Le Doux, 2000; Tronson & Taylor, 2007) . This reconsolidation process is thought to be dynamic, allowing modification of previously formed memories. Consistent with this, numerous studies have shown that reconsolidation can strengthen, weaken or change the specific content of a memory (De Oliveira Alvares et al., 2013; Inda, Muravieva, & Alberini, 2011; Lee, 2008 Lee, , 2010 Monfils, Cowansage, Klann, & LeDoux, 2009; Schiller et al., 2010; Sierra et al., 2013) , which highlights the therapeutic potential of the reconsolidation process in alleviating fear associated with traumatic memories.
While most studies have focused on the mechanisms that regulate the restabilization or protein synthesis-dependent phase of the reconsolidation process, few have examined the mechanisms that regulate memory trace destabilization. NMDA receptor activation appears to initiate the destabilization process as inhibition of NMDA receptor activity in the amygdala prior to retrieval prevents the memory impairments that result from post-retrieval administration of the protein synthesis inhibitor anisomycin (Ben Mamou, Gamache, & Nader, 2006; Lopez, Gamache, Schneider, & Nader, 2015; Wang, de Oliveira Alvares, & Nader, 2009 ). Downstream of NMDA receptors, ubiquitin-proteasome mediated protein degradation has been consistently implicated as a critical regulator of memory trace destabilization since blocking functional proteasome activity prevents memories from undergoing reconsolidation and can attenuate reconsolidation-dependent memory modification (Jarome, Werner, Kwapis, & Helmstetter, 2011; Lee, 2008; Lee et al., 2008) . However, though NMDA receptor activity can result in increased proteasome activity in vitro and in vivo (Bingol & Schuman, 2006; Jarome et al., 2011) , it is hypothesized that this occurs through a second messenger and not as a direct result of calcium influx (Jarome & Helmstetter, 2013) . To date,
